DBV Technologies (DBVT) Other Operating Expenses (2020 - 2026)
DBV Technologies (DBVT) reported Other Operating Expenses of $4.9 million for Q1 2026, up 1533.33% year-over-year from $300000.0 in Q1 2025, and up 259.5% quarter-over-quarter from $1.4 million in Q4 2025.
DBV Technologies (DBVT) Other Operating Expenses (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has 7 years of Other Operating Expenses data on file, last reported at $4.9 million in Q1 2026.
- Other Operating Expenses for Q1 2026 came in at $4.9 million, up 1533.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.9 million (up 257.06% YoY), and the FY2025 annual result was $3.2 million, up 21.17% from the prior year.
- Other Operating Expenses improved to $4.9 million in Q1 2026 per DBVT's latest filing, from $1.4 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $4.9 million in Q1 2026 and troughed at -$51000.0 in Q4 2022.
- A 5-year average of $874352.9 and a median of $519000.0 in 2024 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2022 and 2023: Other Operating Expenses tumbled 270.0% in 2022, then soared 1717.65% in 2023.
- A 5-year view of Other Operating Expenses shows it stood at -$51000.0 in 2022, then soared by 1717.65% to $825000.0 in 2023, then slumped by 52.0% to $396000.0 in 2024, then surged by 244.19% to $1.4 million in 2025, then jumped by 259.5% to $4.9 million in 2026.
- Business Quant data shows DBVT's Other Operating Expenses at $4.9 million in Q1 2026, $1.4 million in Q4 2025, and $1.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.90 Mn |
| Dec 31, 2025 | 1.36 Mn |
| Sep 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 419,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | 396,000.00 |
| Sep 30, 2024 | 519,000.00 |
| Jun 30, 2024 | 986,000.00 |
| Mar 31, 2024 | 757,000.00 |
| Dec 31, 2023 | 825,000.00 |
| Sep 30, 2023 | 663,000.00 |
| Jun 30, 2023 | 517,000.00 |
| Mar 31, 2023 | 433,000.00 |
| Dec 31, 2022 | -51,000.00 |
| Sep 30, 2022 | 159,000.00 |
| Jun 30, 2022 | 1.04 Mn |
| Mar 31, 2022 | 464,000.00 |
| Dec 31, 2021 | 30,000.00 |
| Sep 30, 2021 | 1.07 Mn |
| Jun 30, 2021 | 1.20 Mn |